Resistin in Human Colorectal Cancer: Increased Expression Independently of Resistin Promoter −420C > G genotype

REFERENCES

• Frezza E. E., Wachtel M. S., Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006; 55: 285–291
   PubMed Web of Science ®Google Scholar
• Cowey S., Hardy R. W. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol 2006; 169: 1505–1522
   PubMed Web of Science ®Google Scholar
• Kershaw E. E., Flier J. S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548–2556
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911–919, quiz 920
   PubMed Web of Science ®Google Scholar
• Wei E. K., Giovannucci E., Fuchs C. S., Willett W. C., Mantzoros C. S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 1688–1694
   PubMed Web of Science ®Google Scholar
• Otake S., Takeda H., Suzuki Y., Fukui T., Watanabe S., Ishihama K., Saito T., Togashi H., Nakamura T., Matsuzawa Y., Kawata S. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005; 11: 3642–3646
   PubMed Web of Science ®Google Scholar
• Kang J. H., Yu B. Y., Youn D. S. Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 2007; 22: 117–121
   PubMed Web of Science ®Google Scholar
• Steppan C. M., Brown E. J., Wright C. M., Bhat S., Banerjee R. R., Dai C. Y., Enders G. H., Silberg D. G., Wen X., Wu G. D., Lazar M. A. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001; 98: 502–506
   PubMed Web of Science ®Google Scholar
• Engert J. C., Vohl M. C., Williams S. M., Lepage P., Loredo-Osti J. C., Faith J., Dore C., Renaud Y., Burtt N. P., Villeneuve A., Hirschhorn J. N., Altshuler D., Groop L. C., Despres J. P., Gaudet D., Hudson T. J. 5′ flanking variants of resistin are associated with obesity. Diabetes 2002; 51: 1629–1634
   PubMed Web of Science ®Google Scholar
• McTernan P. G., McTernan C. L., Chetty R., Jenner K., Fisher F. M., Lauer M. N., Crocker J., Barnett A. H., Kumar S. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002; 87: 2407
   PubMed Web of Science ®Google Scholar
• Pagano C., Marin O., Calcagno A., Schiappelli P., Pilon C., Milan G., Bertelli M., Fanin E., Andrighetto G., Federspil G., Vettor R. Increased serum resistin in adults with Prader-Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005; 90: 4335–4340
   PubMed Web of Science ®Google Scholar
• Kaser S., Kaser A., Sandhofer A., Ebenbichler C. F., Tilg H., Patsch J. R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309: 286–290
   PubMed Web of Science ®Google Scholar
• Nagaev I., Bokarewa M., Tarkowski A., Smith U. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE 2006; 1: e31
   PubMedGoogle Scholar
• Reilly M. P., Lehrke M., Wolfe M. L., Rohatgi A., Lazar M. A., Rader D. J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932–939
   PubMed Web of Science ®Google Scholar
• Tang N. P., Wang L. S., Yang L., Zhou B., Gu H. J., Sun Q. M., Cong R. H., Zhu H. J., Wang B. A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease. Clin Chem Lab Med 2007; 45: 1471–1475
   PubMed Web of Science ®Google Scholar
• Konrad A., Lehrke M., Schachinger V., Seibold F., Stark R., Ochsenkuhn T., Parhofer K. G., Goke B., Broedl U. C. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol 2007; 19: 1070–1074
   PubMed Web of Science ®Google Scholar
• Lehrke M., Reilly M. P., Millington S. C., Iqbal N., Rader D. J., Lazar M. A. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 2004; 1: e45
   PubMed Web of Science ®Google Scholar
• Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789–5795
   PubMed Web of Science ®Google Scholar
• Koerner A., Kratzsch J., Kiess W. Adipocytokines: leptin—the classical, resistin–the controversical, adiponectin—the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525–546
   PubMed Web of Science ®Google Scholar
• Degawa-Yamauchi M., Bovenkerk J. E., Juliar B. E., Watson W., Kerr K., Jones R., Zhu Q., Considine R. V. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003; 88: 5452–5455
   PubMed Web of Science ®Google Scholar
• Iqbal N., Seshadri P., Stern L., Loh J., Kundu S., Jafar T., Samaha F. F. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci 2005; 9: 161–165
   PubMedGoogle Scholar
• Conneely K. N., Silander K., Scott L. J., Mohlke K. L., Lazaridis K. N., Valle T. T., Tuomilehto J., Bergman R. N., Watanabe R. M., Buchanan T. A., Collins F. S., Boehnke M. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 2004; 47: 1782–1788
   PubMed Web of Science ®Google Scholar
• Norata G. D., Ongari M., Garlaschelli K., Tibolla G., Grigore L., Raselli S., Vettoretti S., Baragetti I., Noto D., Cefalu A. B., Buccianti G., Averna M., Catapano A. L. Effect of the −420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med 2007; 262: 104–112
   PubMed Web of Science ®Google Scholar
• Osawa H., Yamada K., Onuma H., Murakami A., Ochi M., Kawata H., Nishimiya T., Niiya T., Shimizu I., Nishida W., Hashiramoto M., Kanatsuka A., Fujii Y., Ohashi J., Makino H. The G/G genotype of a resistin single-nucleotide polymorphism at −420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 2004; 75: 678–686
   PubMed Web of Science ®Google Scholar
• Cho Y. M., Youn B. S., Chung S. S., Kim K. W., Lee H. K., Yu K. Y., Park H. J., Shin H. D., Park K. S. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 2004; 47: 559–565
   PubMed Web of Science ®Google Scholar
• Osawa H., Onuma H., Ochi M., Murakami A., Yamauchi J., Takasuka T., Tanabe F., Shimizu I., Kato K., Nishida W., Yamada K., Tabara Y., Yasukawa M., Fujii Y., Ohashi J., Miki T., Makino H. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun 2005; 335: 596–602
   PubMed Web of Science ®Google Scholar
• Smith S. R., Bai F., Charbonneau C., Janderova L., Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003; 52: 1611–1618
   PubMed Web of Science ®Google Scholar
• Choi H. J., Hyun M. S., Jung G. J., Kim S. S., Hong S. H. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998; 55: 575–581
   PubMed Web of Science ®Google Scholar
• Wong M. P., Cheung N., Yuen S. T., Leung S. Y., Chung L. P. Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression. Int J Cancer 1999; 81: 845–850
   PubMed Web of Science ®Google Scholar
• Matrisian L. M., Wright J., Newell K., Witty J. P. Matrix-degrading metalloproteinases in tumor progression. Princess Takamatsu Symp 1994; 24: 152–161
   PubMedGoogle Scholar
• Roeb E., Dietrich C. G., Winograd R., Arndt M., Breuer B., Fass J., Schumpelick V., Matern S. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 2001; 92: 2680–2691
   PubMed Web of Science ®Google Scholar
• Di Simone N., Di Nicuolo F., Sanguinetti M., Castellani R., D'Asta M., Caforio L., Caruso A. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. J Endocrinol 2006; 189: 691–699
   PubMed Web of Science ®Google Scholar
• Mu H., Ohashi R., Yan S., Chai H., Yang H., Lin P., Yao Q., Chen C. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res 2006; 70: 146–157
   PubMed Web of Science ®Google Scholar
• Schaffler A., Scholmerich J., Buchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue—emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 103–111
   PubMedGoogle Scholar
• Bertolani C., Sancho-Bru P., Failli P., Bataller R., Aleffi S., DeFranco R., Mazzinghi B., Romagnani P., Milani S., Gines P., Colmenero J., Parola M., Gelmini S., Tarquini R., Laffi G., Pinzani M., Marra F. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 2006; 169: 2042–2053
   PubMed Web of Science ®Google Scholar
• Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001; 357: 539–545
   PubMed Web of Science ®Google Scholar
• Coussens L. M., Werb Z. Inflammation and cancer. Nature 2002; 420: 860–867
   PubMed Web of Science ®Google Scholar
• Chung Y. C., Chaen Y. L., Hsu C. P. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma. Anticancer Res 2006; 26: 3905–3911
   PubMed Web of Science ®Google Scholar
• Baier P. K., Wolff-Vorbeck G., Eggstein S., Baumgartner U., Hopt U. T. Cytokine expression in colon carcinoma. Anticancer Res 2005; 25: 2135–2139
   PubMed Web of Science ®Google Scholar
• Miki C., Tonouchi H., Wakuda R., Hatada T., Inoue Y., Minato E., Kobayashi M., Kusunoki M. Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma. Cancer 2002; 94: 1584–1592
   PubMed Web of Science ®Google Scholar